These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23945304)
1. [The efficacy and safety of unmanipulated haploidentical peripheral blood stem cell transplantation on hematologic diseases]. Huang WR; Li HH; Jin XS; Wang SH; Bo J; Zhao Y; Jing Y; Zhu HY; Dou LP; Jia BJ; Wang QS; Gao CJ; Yu L Zhonghua Nei Ke Za Zhi; 2013 May; 52(5):390-4. PubMed ID: 23945304 [TBL] [Abstract][Full Text] [Related]
2. Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies. Huang W; Li H; Gao C; Bo J; Wang Q; Zhao Y; Jing Y; Wang S; Zhu H; Dou L; Wang L; Yu L Transfusion; 2012 Jun; 52(6):1354-62. PubMed ID: 22233440 [TBL] [Abstract][Full Text] [Related]
3. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
4. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
5. [Non-T-cell depleted HLA haploidentical peripheral blood stem cell transplantation for hematological malignancies: report of 36 cases]. Yuan HL; Li L; Qu JH; Wen BZ; Jiang M; Hao JP; Chen R; Guo XH; Halida Y; Wang SZ; Ding LL Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):82-6. PubMed ID: 19563016 [TBL] [Abstract][Full Text] [Related]
6. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of immunological reconstitution and related complications after HLA-matched and HLA haploidentical peripheral blood hematopoietic stem cell transplantation]. Li L; Yuan HL; Wen BZ; Zhong D; Qu JH; Jiang M; Halida Y; Guo XH; Hao JP Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):204-7. PubMed ID: 20450650 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of peripheral blood stem cell transplantation in patients from human leukocyte antigen matched or mismatched unrelated donors. Cao T; Li Y; Wang Q; Li H; Bo J; Zhao Y; Jing Y; Wang S; Zhu H; Dou L; Jia B; Gao C; Yu L; Huang W Chin Med J (Engl); 2014; 127(14):2612-7. PubMed ID: 25043076 [TBL] [Abstract][Full Text] [Related]
9. [The outcomes of the thirty patients with refractory leukemia treated with related HLA haploidentical stem cells transplantation]. Wu BY; Guo KY; Song CY; Wu LX; Yang YL; Li YH; Xiao LL Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):130-2. PubMed ID: 16624123 [TBL] [Abstract][Full Text] [Related]
10. The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis. Xu LP; Liu KY; Liu DH; Chen H; Han W; Chen YH; Wang Y; Huang XJ Bone Marrow Transplant; 2010 Jun; 45(6):985-92. PubMed ID: 19898505 [TBL] [Abstract][Full Text] [Related]
11. Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies. Yamasaki S; Ohno Y; Taniguchi S; Yoshida T; Hayashi S; Ogawa H; Shimazaki C; Takahashi S; Kasai M; Wake A; Nishimura M; Tokunaga K; Gondo H; Takaue Y; Harada M; Mineishi S; Bone Marrow Transplant; 2004 Feb; 33(3):279-89. PubMed ID: 14647250 [TBL] [Abstract][Full Text] [Related]
13. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center. Huang X; Liu D Clin Transpl; 2011; ():237-45. PubMed ID: 22755417 [TBL] [Abstract][Full Text] [Related]
14. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956 [TBL] [Abstract][Full Text] [Related]
15. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073 [TBL] [Abstract][Full Text] [Related]
16. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704 [TBL] [Abstract][Full Text] [Related]
17. Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial. Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A Biol Blood Marrow Transplant; 2012 Dec; 18(12):1859-66. PubMed ID: 22863841 [TBL] [Abstract][Full Text] [Related]
18. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582 [TBL] [Abstract][Full Text] [Related]
19. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Wang Y; Liu DH; Liu KY; Xu LP; Zhang XH; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Sun YQ; Huang XJ Cancer; 2013 Mar; 119(5):978-85. PubMed ID: 23097265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]